Clinical Pathology · MU Sofia

73. Primary tumors of the lung and pleura – benign & malignant. Histological and macroscopic forms.

Covers the main primary lung cancers: adenocarcinoma, squamous cell carcinoma, large cell carcinoma and small cell carcinoma, each with its genes, risk factors, location, histology and diagnostic markers. Also outlines hamartoma as the commonest benign lung tumour and malignant mesothelioma as the main primary pleural tumour, with its gross appearance and three histological patterns. Includes a squamous cell carcinoma gross picture and a memory aid linking tumour types to paraneoplastic syndromes.

Inside: 1 section · 1 labelled picture · 16 flashcards · 4 min

Topic 73 of 138 in the MU Sofia syllabus for Clinical Pathology (Medicine, Year 4). The free AceMed note covers it in 1 section, about 594 words (4 min of reading), with 16 flashcards.

In this note

  1. Primary tumours of the lung and pleura - benign & malignant. Histological and macroscopic forms

Primary tumours of the lung and pleura - benign & malignant. Histological and macroscopic forms

Main types of primary malignant lung tumours:

  • Non-Small-Cell lung cancer types
  • Adenocarcinoma (40%)
  • Squamous Cell Carcinoma (25-30%)
  • Large cell carcinoma (10-15%)
  • Small Cell Lung Cancer (Small Cell Carcinoma - 15-20%)

Adenocarcinoma

  • Genes that mutate to allow adenocarcinoma development: EGFR, ALK, ROS, KRAS
  • Smoking is still the main risk factor, but it is also the most common type in non-smokers, especially women.
  • May occur as central lesion, but more commonly peripherally located
  • They grow slowly, and form smaller masses than other subtypes, but metastasise earlier
  • Histological form may be acinar (gland-forming), papillary, mucinous or solid type.
  • Precancerous lesion is adenocarcinoma in situ, with hyperplasia and fibrosis of alveolar walls
  • Diagnosis through direct observation of enlarged glands or increased mucin production. If this is not observed, should perform immunohistochemistry to observe TTF antibodies

Squamous Cell Carcinoma

  • Gene that mutates to allow carcinoma is TP53
  • Main etiological cause is smoking (99% of patients are smokers)
  • Lesions tend to arise centrally in major bronchi, close to the hilum, causing central necrosis and cavitation
  • Often produce productive cough, the sputum of which may contain cancerous cells which can be examined under a microscope.
  • SCC’s produce keratinisation of cells, with keratin pearls on histological examination. These prove the diagnostic gold standard, without this, observe antibodies P40 and cytokeratin 5 & 6.
  • Pre cancerous lesion is squamous metaplasia or dysplasia of bronchial epithelium, which then progresses to carcinoma in situ.

Gross: central squamous cell carcinoma. A firm grey-white tumour involves the main bronchi at the carina and has spread to the subcarinal lymph nodes; the surrounding lung is black with smoker's pigment.

Image: “Squamous cell carcinoma (3950818822)” by Yale Rosen from USA, CC BY-SA 2.0, via Wikimedia Commons.

Large Cell Carcinoma

  • Can appear in any part of the lung, presents as a non-productive cough with weight loss
  • It is diagnosis by exclusion, as the tumour cells lack the characteristics that would define them as other non-small cell carcinomas or small cell carcinomas.
  • Comprises 5-10% of all lung cancers

Small cell carcinoma

  • Genes that mutate are TP53, Retinoblastoma gene (RB) and Transcription factor coder MYC
  • Lesions generally located centrally, but can be peripheral
  • Typical growth is subepithelial, and so invisible underneath the mucosa of the bronchi, diagnosis may have to be via a blind biopsy
  • Often metastasizes into the mediastinum, with enlarged lymph nodes present
  • Highly proliferative tumour, surgery not an option, chemotherapy and radiotherapy are prefered

Continue reading free

The whole note is free with an AceMed account, with its 16 flashcards. Premium adds flashcard recall, highlights and Ask AI.